Tetrazolylglycine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Tetrazolylglycine
Chemical structure of tetrazolylglycine
Names
IUPAC name
(RS)-Amino(1H-tetrazol-5-yl)acetic acid
Identifiers
3D model (JSmol)
  • Interactive image
ChEMBL
  • ChEMBL140784 ☑Y
ChemSpider
  • 112321 ☑Y
  • 4068
PubChem CID
  • 126383
Properties
C3H5N5O2
Molar mass 143.11 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
‹See TfM›☒N verify (what is ☑Y‹See TfM›☒N ?)
Infobox references

Tetrazolylglycine (Tet-Gly, LY-285,265) is a potent and selective NMDA receptor agonist, stimulating the NMDA receptor with higher potency than either glutamate or NMDA.[1] It is a potent convulsant and excitotoxin and is used in scientific research.[2][3]

References

  1. ^ Lunn WH, Schoepp DD, Calligaro DO, Vasileff RT, Heinz LJ, Salhoff CR, O'Malley PJ (1992). "DL-tetrazol-5-ylglycine, a highly potent NMDA agonist: its synthesis and NMDA receptor efficacy". Journal of Medicinal Chemistry. 35 (24): 4608–12. doi:10.1021/jm00102a015. PMID 1361579.
  2. ^ Schoepp DD, Smith CL, Lodge D, Millar JD, Leander JD, Sacaan AI, Lunn WH (1991). "D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist". European Journal of Pharmacology. 203 (2): 237–43. doi:10.1016/0014-2999(91)90719-7. PMID 1686860.
  3. ^ Schoepp DD, Lunn WH, Salhoff CR, McDonald JW (1994). "The NMDA receptor agonist DL-(tetrazol-5-yl)glycine is a highly potent excitotoxin". European Journal of Pharmacology. 270 (1): 67–72. doi:10.1016/0926-6917(94)90081-7. PMID 8157082.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Tetrazolylglycine&oldid=863096543"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/Tetrazolylglycine
This page is based on the copyrighted Wikipedia article "Tetrazolylglycine"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA